Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NALMEFENE vs NALOXEGOL OXALATE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NALMEFENE vs NALOXEGOL OXALATE: Safety Overview

Metric NALMEFENE NALOXEGOL OXALATE
Total FAERS Reports 197 2,212
Deaths Reported 77 154
Death Rate 39.1% 7.0%
Hospitalizations 118 335
Average Patient Age 44.2 yrs 63.7 yrs
% Female Patients 39.3% 58.0%
FDA Approval Date Apr 17, 1995 Sep 16, 2014
Manufacturer Purdue Pharma L.P. RedHill Biopharma Ltd
Route INTRAMUSCULAR ORAL
Marketing Status Discontinued Prescription